300357.SZ SHZ
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.
1W: +0.7%
1M: -9.1%
3M: -14.9%
YTD: -26.9%
1Y: -22.1%
3Y: -40.1%
5Y: -65.3%
¥20.33 ($3.03)
+0.51 (+2.57%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$262M
-31.3% ▼
5Y CAGR: +2.4%
Capital Expenditures
$118M
+43.6% ▲
5Y CAGR: +3.4%
Free Cash Flow
$144M
-16.5% ▼
5Y CAGR: +1.7%
Dividends Paid
$97M
+6.9% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$480M
-387.6% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $270M | $326M | $336M | $296M | $304M |
| Depreciation & Amort. | $15M | $25M | $26M | $38M | $51M |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$26M | $11M | -$47M | $47M | -$91M |
| Other Non-Cash Items | -$2M | -$2M | $46M | $7M | -$1M |
| Operating Cash Flow | $256M | $361M | $360M | $388M | $262M |
| — Investing Activities — | |||||
| Capital Expenditures | -$70M | -$122M | -$189M | -$209M | -$118M |
| Acquisitions (Net) | $470 | -$0 | $215K | $86M | $0 |
| Investment Purchases | -$363M | -$843M | -$484M | -$600M | -$683M |
| Investment Sales | $337M | $743M | $518M | $606M | $207M |
| Other Investing | $5M | $10M | $37M | $5M | -$2M |
| Investing Cash Flow | -$91M | -$212M | -$118M | -$112M | -$596M |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | -$6M | -$6M | $5M | -$41M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | -$94M | -$84M | -$105M | -$105M | -$97M |
| Other Financing | $0 | $0 | $0 | -$9M | -$8M |
| Financing Cash Flow | -$94M | -$90M | -$111M | -$109M | -$147M |
| Net Change in Cash | $71M | $59M | $131M | $167M | -$480M |
| Cash End of Period | $221M | $280M | $411M | $578M | $98M |
| Free Cash Flow | $186M | $238M | $172M | $173M | $144M |